A global stem cell research and therapeutics company in Torrance may have a blueprint for saving lives in the future.

Celprogen announced today they have successfully finished printing a 3D scaffold human heart that could one day be used for heart transplants. It is made of flexible polylactic acid and adult human cardiac stem cells.

The flexible part allows the seeded cardiac stem cells to potentially contract. The print was reduced from a young adult heart to a quarter of its original size. Celprogen says it’s a good model for cardiac toxicity studies.

The company has been around since 2002, and they focus on developing technologies that help with medicine.